K-562-GFP Cells
USD 800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Información general
| Descripción | K-562-GFP cells are a genetically modified variant of the human chronic myelogenous leukemia (CML) cell line K-562, originally derived from the peripheral blood of an adult patient in blast crisis. The parental K-562 line is characterized by the presence of the Philadelphia chromosome, resulting in the BCR-ABL fusion protein with constitutive tyrosine kinase activity, which drives uncontrolled proliferation and survival. K-562 cells exhibit erythroleukemia features and can be induced to undergo differentiation along erythroid, megakaryocytic, or monocytic lineages under specific experimental conditions, making them a versatile model for studying hematopoietic differentiation and leukemia biology. The introduction of green fluorescent protein (GFP) into K-562 cells enables real-time visualization and tracking of leukemic cell behavior in vitro and in vivo. K-562-GFP cells are widely used in assays involving cell proliferation, migration, and drug response, as well as in co-culture systems to study interactions with stromal or immune cells. The fluorescent labeling facilitates applications such as flow cytometry, live-cell imaging, and high-throughput screening. |
|---|---|
| Organismo | Human |
| Tejido | Pleural effusion |
| Enfermedad | Chronic myeloid leukemia |
Características
| Edad | 53 years |
|---|---|
| Género | Female |
| Origen étnico | Caucasian |
| Morfología | Lymphoblast-like |
| Tipo de célula | Lymphoblast |
| Propiedades de crecimiento | Suspension |
Datos normativos
| Referencia | K562-GFP (Cytion catalog number 305948) |
|---|---|
| Nivel de bioseguridad | 1 |
| NCBI_TaxID | 9606 |
| N.º de acceso de Cellosaurus | CVCL_1G55 |
Datos biomoleculares
| Expresión de proteínas | GFP |
|---|---|
| Perfil mutacional | Mutation: p.Gln136fs*13, Homozygous |
Manejo
| Medio de cultivo | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reactivo de disociación | None |
| Subcultivo | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Densidad de siembra | 0.3 to 1 x 106 cells/ml |
| Renovación de fluidos | 2 to 3 times per week |
| Medio de congelación | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Descongelación y cultivo de células |
|
| Atmósfera de incubación | 37°C, 5% CO2, humidified atmosphere. |
| Condiciones de envío | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condiciones de almacenamiento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Control de calidad y análisis molecular
Certificado de análisis (CoA)
| Número de lote | Tipo de certificado | Fecha | Número de catálogo |
|---|---|---|---|
| 305948-120326 | Certificado de análisis | 13. Apr. 2026 | 305948 |